|
US6077823A
(en)
*
|
1991-03-11 |
2000-06-20 |
Creative Biomolecules, Inc. |
Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury
|
|
CA2363965C
(en)
*
|
1991-03-11 |
2010-05-18 |
Curis, Inc. |
Protein-induced morphogenesis
|
|
US20030167492A1
(en)
|
1994-07-08 |
2003-09-04 |
Johns Hopkins University School Of Medicine |
Transgenic non-human animals expressing a gdf-11 dominant negative polypeptide, and methods of making and using same
|
|
US6498142B1
(en)
*
|
1996-05-06 |
2002-12-24 |
Curis, Inc. |
Morphogen treatment for chronic renal failure
|
|
AU743510B2
(en)
|
1997-05-05 |
2002-01-24 |
Stryker Corporation |
Therapies for acute renal failure
|
|
WO1998050061A1
(en)
*
|
1997-05-07 |
1998-11-12 |
Biogen, Inc. |
Novel therapies for cystic kidney disease
|
|
DE69714035T2
(de)
|
1997-08-14 |
2003-03-06 |
Sulzer Innotec Ag, Winterthur |
Zusammensetzung und Vorrichtung zur Reparatur von Knorpelgewebe in vivo bestehend aus Nanokapseln mit osteoinduktiven und/oder chondroinduktiven Faktoren
|
|
US6203788B1
(en)
*
|
1997-09-29 |
2001-03-20 |
Adherex Inc. |
Compounds and methods for regulating cell adhesion
|
|
WO1999028341A2
(en)
*
|
1997-12-04 |
1999-06-10 |
Creative Biomolecules, Inc. |
Maintenance of smooth muscle integrity by morphogenic proteins
|
|
NZ509609A
(en)
*
|
1998-07-28 |
2003-11-28 |
Univ Johns Hopkins Med |
Disrupting growth differentiation factor-11 (GDF-11) to increase the muscle and bone tissue in animals
|
|
US7087577B2
(en)
*
|
1998-10-16 |
2006-08-08 |
Zimmer Orthobiologies, Inc. |
Method of promoting natural bypass
|
|
US6992066B2
(en)
|
1998-10-16 |
2006-01-31 |
Zimmer Orthobiologics, Inc. |
Povidone-containing carriers for polypeptide growth factors
|
|
EP1214091B1
(en)
*
|
1999-09-14 |
2006-05-10 |
Biogen Idec MA Inc. |
Therapies for chronic renal failure using one or more integrin antagonists
|
|
US20020173453A1
(en)
*
|
2000-12-15 |
2002-11-21 |
Rama Akella |
Method of treating renal injury
|
|
US7763769B2
(en)
|
2001-02-16 |
2010-07-27 |
Kci Licensing, Inc. |
Biocompatible wound dressing
|
|
US7700819B2
(en)
|
2001-02-16 |
2010-04-20 |
Kci Licensing, Inc. |
Biocompatible wound dressing
|
|
US7232802B2
(en)
|
2001-12-21 |
2007-06-19 |
Zimmer Orthobiologics, Inc. |
Compositions and methods for promoting myocardial and peripheral angiogenesis
|
|
US7622562B2
(en)
|
2002-06-26 |
2009-11-24 |
Zimmer Orthobiologics, Inc. |
Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue
|
|
WO2004019876A2
(en)
*
|
2002-08-28 |
2004-03-11 |
Curis, Inc. |
Conjoint administration of morphogens and ace inhibitors in treatment of chronic renal failure
|
|
DK1677735T3
(da)
|
2003-10-17 |
2014-10-27 |
Joslin Diabetes Center Inc |
Fremgangsmåder og sammensætninger til modulering af adipocytfunktion
|
|
US7844367B2
(en)
|
2003-12-23 |
2010-11-30 |
Rain Bird Corporation |
Code replacement for irrigation controllers
|
|
KR101153035B1
(ko)
*
|
2004-03-30 |
2012-06-11 |
리립사, 인크. |
이온 결합 조성물
|
|
CA2561809A1
(en)
*
|
2004-03-31 |
2005-10-20 |
Xencor, Inc. |
Bmp-7 variants with improved properties
|
|
US20100150885A1
(en)
*
|
2005-06-01 |
2010-06-17 |
Joslin Diabetes Center, Inc. |
Methods and compositions for inducing brown adipogenesis
|
|
US7771995B2
(en)
*
|
2005-11-14 |
2010-08-10 |
Merial Limited |
Plasmid encoding human BMP-7
|
|
EP1951751B1
(en)
*
|
2005-11-14 |
2017-11-01 |
Merial, Inc. |
Gene therapy for renal failure
|
|
EP1978802A2
(en)
*
|
2006-01-24 |
2008-10-15 |
Northfield Laboratories, Inc. |
Polymerized hemoglobin media and its use in isolation and transplantation of islet cells
|
|
US20090004159A1
(en)
*
|
2006-01-24 |
2009-01-01 |
The Board Of Trustees Of The University Of Illinoi |
Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells
|
|
US20080090765A1
(en)
*
|
2006-05-25 |
2008-04-17 |
The Trustees Of Columbia University In The City Of New York |
Compositions for modulating growth of embryonic and adult kidney tissue and uses for treating kidney damage
|
|
PL2035835T3
(pl)
|
2006-05-30 |
2012-05-31 |
Antibodyshop As |
Sposoby szybkiej oceny ciężkości urazu
|
|
US7722665B2
(en)
*
|
2006-07-07 |
2010-05-25 |
Graft Technologies, Inc. |
System and method for providing a graft in a vascular environment
|
|
EP2047862B9
(en)
*
|
2006-07-21 |
2013-04-10 |
Chugai Seiyaku Kabushiki Kaisha |
Remedy for renal disease
|
|
WO2008075173A2
(en)
*
|
2006-12-15 |
2008-06-26 |
Ruprecht-Karls-Universität Heidelberg |
Methods for treating podocyte-related disorders
|
|
WO2008134297A2
(en)
*
|
2007-04-24 |
2008-11-06 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Engineered renal tissue
|
|
DE102007034580B4
(de)
*
|
2007-07-13 |
2012-11-08 |
NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen |
Biomaterial basierend auf einem hydrophilen polymeren Träger
|
|
US20090155245A1
(en)
*
|
2007-12-18 |
2009-06-18 |
Fang Carrie H |
Treatment for Organ Regeneration with Combination of Drug and Biologics
|
|
WO2009137613A2
(en)
*
|
2008-05-06 |
2009-11-12 |
Joslin Diabetes Center, Inc. |
Methods and compositions for inducing brown adipogenesis
|
|
WO2009157165A1
(ja)
*
|
2008-06-24 |
2009-12-30 |
株式会社根本杏林堂 |
薬液注入装置、この薬液注入装置を有する透視撮像システム、薬液注入装置のコンピュータプログラムおよびデータ処理方法
|
|
JP2012501456A
(ja)
*
|
2008-08-28 |
2012-01-19 |
アスチュート メディカル，インコーポレイテッド |
腎損傷および腎不全の診断および予後のための方法および組成物
|
|
CA2735590A1
(en)
*
|
2008-08-29 |
2010-03-04 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
WO2010048346A1
(en)
|
2008-10-21 |
2010-04-29 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
EP2767833A3
(en)
*
|
2008-10-21 |
2014-12-17 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
CN104330574B
(zh)
|
2008-11-10 |
2017-04-12 |
阿斯图特医药公司 |
用于诊断和预后肾损伤和肾衰竭的方法和组合物
|
|
EP2364370B1
(en)
*
|
2008-11-22 |
2014-09-03 |
Astute Medical, Inc. |
Methods for prognosis of acute renal failure
|
|
CN102369293B
(zh)
*
|
2009-02-06 |
2014-05-28 |
阿斯图特医药公司 |
肾损伤和肾衰竭的诊断及预后
|
|
US9229010B2
(en)
|
2009-02-06 |
2016-01-05 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
EP2396026A2
(en)
*
|
2009-02-12 |
2011-12-21 |
Stryker Corporation |
Compositions and methods for minimally-invasive systemic delivery of proteins including tgf- superfamily members
|
|
US20100204123A1
(en)
|
2009-02-12 |
2010-08-12 |
Mary Elizabeth Pecquet Goad |
Peripheral Administration of Proteins Including TGF-beta Superfamily Members for Treatment of Systemic Disorders and Disease
|
|
AU2010223268B2
(en)
*
|
2009-03-12 |
2015-04-23 |
Haase Investments Gmbh |
Bone morphogenetic protein 2 (BMP2 ) variants with reduced BMP antagonist sensitivity
|
|
US20110002897A1
(en)
|
2009-06-11 |
2011-01-06 |
Burnham Institute For Medical Research |
Directed differentiation of stem cells
|
|
KR20120061863A
(ko)
|
2009-08-07 |
2012-06-13 |
아스튜트 메디컬 인코포레이티드 |
신장 손상 및 신부전증의 진단과 예후를 위한 방법 및 조성물
|
|
EP2352750B1
(en)
|
2009-09-17 |
2012-06-13 |
Stryker Corporation |
Buffers for controlling the ph of bone morphogenetic proteins
|
|
MX340078B
(es)
|
2009-11-07 |
2016-06-24 |
Astute Medical Inc |
Metodos y composiciones para el diagnostico y pronostico de daño renal y falla renal.
|
|
MX342967B
(es)
|
2009-12-20 |
2016-10-19 |
Astute Medical Inc |
Metodos y composiciones para la diagnosis y prognosis de lesion renal y falla renal.
|
|
CA2785038A1
(en)
|
2009-12-22 |
2011-07-21 |
Stryker Corporation |
Bmp-7 variants with reduced immunogenicity
|
|
CN102791885B
(zh)
|
2010-02-05 |
2015-09-09 |
阿斯图特医药公司 |
用于肾损伤和肾衰竭的诊断及预后的方法和组合物
|
|
EP2539712A4
(en)
|
2010-02-26 |
2013-09-18 |
Astute Medical Inc |
METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
|
|
JP2013529907A
(ja)
|
2010-05-24 |
2013-07-25 |
ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク |
Ｎｇａｌタンパク質変異体及びその使用
|
|
NZ605698A
(en)
|
2010-06-23 |
2015-03-27 |
Astute Medical Inc |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
IN2012MN02812A
(enExample)
|
2010-06-23 |
2015-05-22 |
Astute Medical Inc |
|
|
US9688735B2
(en)
|
2010-08-20 |
2017-06-27 |
Wyeth Llc |
Designer osteogenic proteins
|
|
PH12013500294A1
(en)
|
2010-08-20 |
2017-08-23 |
Wyeth Llc |
Designer osteogenic proteins
|
|
EP3540440B1
(en)
|
2011-12-08 |
2022-09-28 |
Astute Medical, Inc. |
Methods and uses for evaluating renal injury and renal status
|
|
ES3059226T3
(en)
|
2012-10-08 |
2026-03-19 |
Vifor Int Ltd |
Potassium-binding agents for treating hypertension and hyperkalemia
|
|
EP2925337B1
(en)
|
2012-11-21 |
2019-07-03 |
The Trustees of Columbia University in the City of New York |
Mutant ngal proteins and uses thereof
|
|
JP6681195B2
(ja)
|
2013-01-17 |
2020-04-15 |
アスチュート メディカル，インコーポレイテッド |
腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
|
|
US8956829B2
(en)
|
2013-01-25 |
2015-02-17 |
Warsaw Orthopedic, Inc. |
Human recombinant growth and differentiaton factor-5 (rhGDF-5)
|
|
US9169308B2
(en)
|
2013-01-25 |
2015-10-27 |
Warsaw Orthopedic, Inc. |
Methods and compositions of human recombinant growth and differentiation factor-5 (rhGDF-5) isolated from inclusion bodies
|
|
US9051389B2
(en)
|
2013-01-25 |
2015-06-09 |
Warsaw Orthopedic, Inc. |
Expression conditions and methods of human recombinant growth and differentiation factor-5 (rhGDF-5)
|
|
US9359417B2
(en)
|
2013-01-25 |
2016-06-07 |
Warsaw Orthopedic, Inc. |
Cell cultures and methods of human recombinant growth and differentiaton factor-5 (rhGDF-5)
|
|
US8945872B2
(en)
|
2013-01-25 |
2015-02-03 |
Warsaw Orthopedic, Inc. |
Methods of purifying human recombinant growth and differentiation factor-5 (rhGDF-5) protein
|
|
EP2784083A1
(en)
|
2013-03-28 |
2014-10-01 |
Charité - Universitätsmedizin Berlin |
Bone Morphogenetic Protein (BMP) variants with highly reduced antagonist sensitivity and enhanced specific biological activity
|
|
EP3069149B1
(en)
*
|
2013-11-11 |
2022-05-18 |
General Electric Company |
Method for reducing error in rotor speed measurements
|
|
EP2944326B1
(en)
|
2014-05-16 |
2018-11-21 |
Cyanagen Srl |
Tricarbocyanine-cyclodextrin-conjugates and their use for the diagnosis of kidney diseases
|
|
US11241505B2
(en)
|
2015-02-13 |
2022-02-08 |
Factor Bioscience Inc. |
Nucleic acid products and methods of administration thereof
|
|
AU2017277305A1
(en)
|
2016-06-06 |
2018-12-20 |
Astute Medical, Inc. |
Management of acute kidney injury using insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2
|
|
IL264439B2
(en)
|
2016-08-17 |
2024-08-01 |
Factor Bioscience Inc |
non-viral, cell-free composition comprising a synthetic messenger RNA (MRNA) encoding a gene-editing protein for use in treating cancer, and a synthetic RNA encoding a gene-editing protein for use in treatment
|
|
JP2019039673A
(ja)
*
|
2017-08-22 |
2019-03-14 |
セイコーエプソン株式会社 |
時間デジタル変換回路、回路装置、物理量測定装置、電子機器及び移動体
|